医学
噻唑烷二酮
罗格列酮
2型糖尿病
重症监护医学
二甲双胍
糖尿病
内分泌学
摘要
Despite a large need for new hypoglycemic therapies, given the epidemic of type 2 diabetes, very few agents have been introduced during the past 20 years. The thiazolidinediones represent a potentially important new group of drugs with a mechanism of action differing from and perhaps complementary to that of existing therapies. This article discusses present data on mechanisms, indications, and limitations of thiazolidinedione therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI